Empire State Development (ESD) serves as New York's primary economic development agency, established in 1995 and headquartered in New York City. Its mission focuses on fostering business investment and growth to stimulate job creation and enhance community prosperity throughout the state. ESD operates as the umbrella organization for the New York State Urban Development Corporation and the Job Development Authority, coordinating various initiatives to support economic development. The agency's investments and projects are overseen by a board of directors, ensuring alignment with its goals of promoting sustainable economic growth in New York.
SimpliFed is a telehealth company founded in 2020 that offers virtual breastfeeding support to new and pregnant parents. The company focuses on providing accessible care during the peri and postnatal periods, addressing the challenges faced by parents, including sleep deprivation and concerns about infant nutrition. SimpliFed specializes in lactation and baby feeding support, as well as monitoring high-risk conditions such as hypertension and gestational diabetes. Through secure online and video-based connections, patients can engage with care navigators who guide them through their maternal care journey, helping them obtain quick answers to their questions about their infants' dietary needs.
Rochester Technology and Manufacturing Association
Grant in 2024
The Rochester Technology and Manufacturing Association (RTMA) fosters manufacturing innovation and growth. By collaborating with businesses, academia, and government, RTMA helps the local manufacturing community.
Daystar Kids
Grant in 2024
Daystar Kids is a nonprofit organization that provides therapeutic, educational enrichment, and family support services.
RochesterWorks
Grant in 2024
RochesterWorks! is Monroe County's leading employment and training initiative, focused on fostering a robust workforce in the Rochester, NY area. The organization offers complimentary services to job seekers, youth, and businesses through two full-service Career Centers located at 255 North Goodman Street and 276 Waring Road. RochesterWorks! provides various workforce services, including recruitment, assessment, placement, and training for businesses, while also connecting them to federally-funded employment and training programs. This comprehensive approach aims to streamline the hiring process for employers, ultimately saving them time and resources.
FuzeHub
Grant in 2024
FuzeHub is a not-for-profit organization that provides assistance to small- to medium-sized manufacturing companies. They offer support in areas such as technology commercialization, workforce development, and supply chain optimization. By connecting companies with resources, expertise, and funding opportunities, FuzeHub aims to help these businesses grow and thrive in the competitive manufacturing industry. Through their network of industry experts and partnerships, FuzeHub serves as a valuable resource for manufacturers looking to innovate, improve productivity, and stay ahead of market trends.
Envisagenics
Series B in 2024
Envisagenics, Inc. is a biotechnology company founded in 2013 and headquartered in Huntington, New York. It specializes in the development of a predictive analytics platform aimed at accelerating the discovery of RNA therapeutics. The company leverages advanced artificial intelligence and machine learning algorithms to analyze transcriptomic data, helping researchers identify and validate potential drug targets. Envisagenics' flagship technology, SpliceCore, is a cloud-based platform that utilizes RNA splicing analytics to predict drug targets and biomarkers, addressing the complexities of biomedical data. Given that over 30 million people in the U.S. suffer from genetic diseases or cancers related to RNA splicing errors, the company's mission is to streamline the development of innovative therapeutic solutions. By providing an in-silico RNA therapeutics discovery platform, Envisagenics enhances the efficiency of drug development processes, reducing time, cost, and risk associated with bringing new therapies to market through partnerships with biopharmaceutical companies.
FIFCO
Grant in 2024
FIFCO renders brewing, packaging, importing, marketing and selling services.
WISE Women’s Business Center
Grant in 2024
WISE Women’s Business Center provide comprehensive business training and counseling.
Dimensional Energy
Series A in 2023
Dimensional Energy is a chemistry company focused on pioneering artificial photosynthesis to create environmentally friendly polymers and chemical intermediates. The company develops technology that utilizes and distributes sunlight in scalable reactor systems, effectively capturing and converting carbon dioxide into hydrocarbon fuels. By employing innovative waveguides, Dimensional Energy ensures even distribution of sunlight within its reactors, enhancing the reactivity of carbon dioxide molecules through functionalized catalysts. This approach aims to provide viable solar fuels, addressing critical energy needs while promoting sustainability.
Mohawk Valley EDGE
Grant in 2023
Mohawk Valley EDGE is a nonprofit economic development agency located in Rome, New York. It plays a vital role in fostering economic growth in Oneida County by supporting the establishment and expansion of businesses and industries. The agency collaborates with both public and private sectors to create opportunities for new ventures, aiming to enhance the local economy. Managed by a board of members, Mohawk Valley EDGE coordinates various programs and resources designed to assist businesses in their growth and development initiatives.
Stark Truss Company
Grant in 2023
Stark Truss Company is a building materials company that manufactures roof and floor trusses.
Wcny
Grant in 2023
WCNY is Central New York’s public broadcasting company, providing great local and national programming, high-quality educational television.
Deerfield Capital
Grant in 2023
Deerfield Management, established in 1994 and headquartered in New York, is a healthcare-focused investment management firm. It provides long-term structured investments in both public and private healthcare companies, spanning life science, medical device, diagnostic, digital health, and health service industries. The firm also offers information and investment services to foster a healthcare ecosystem.
Applied DNA Sciences
Grant in 2023
Applied DNA Sciences, Inc. is a biotechnology company specializing in DNA-based technology solutions for various applications, including diagnostics, drug development, supply chain security, and anti-counterfeiting. The company operates through three main segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. Its offerings include SigNature molecular tags for product authentication and supply chain protection, SigNify portable DNA readers for real-time tag verification, and CertainT Supply Chain Platform for validating product claims. Additionally, Applied DNA Sciences manufactures COVID-19 PCR-based diagnostic test kits and provides non-diagnostic pooled surveillance testing. Established in 1983 and headquartered in Stony Brook, New York, the company was formerly known as Datalink Systems, Inc. and rebranded in 2002.
LIDROTEC
Grant in 2022
Lidrotec is a company focused on enhancing the capabilities of production and manufacturing through the use of ultra-short pulse lasers. It has developed a specialized wafer dicing laser machine that employs ultrashort pulse processing technology. This innovative approach enables high-precision cutting, drilling, and structuring of various materials, particularly benefiting the semiconductor industry. By utilizing this advanced technology, Lidrotec aims to improve processing speeds while ensuring maximum accuracy in manufacturing processes.
LocalCoho
Grant in 2022
LocalCoho is a farm-to-table fish company established in 2016 and based in Auburn, NY. The company specializes in providing sustainably sourced local fish to regional markets, with a focus on high-quality salmon. LocalCoho's salmon is derived from non-GMO, certified organic eggs and is raised responsibly, ensuring a product that is both flavorful and nutritious. The fish is characterized by its rich, reddish-orange meat and healthy oil content, offering customers a versatile and delicious seafood option.
Magnolia NeuroSciences
Series A in 2018
Magnolia Neurosciences Corporation is a New York-based company focused on drug discovery and development, specifically targeting neuroprotective therapies for central nervous system diseases and neurodegeneration. Established in 2018, the company aims to create proprietary small molecule therapeutics that prevent neuronal cell death, offering new treatment options for patients with neurodegenerative disorders and related conditions. Magnolia Neurosciences was founded to advance technologies developed at The University of Texas MD Anderson Cancer Center’s Therapeutics Discovery Division and the Neurodegeneration Consortium. Through its innovative approach, the company seeks to address significant medical needs in the field of neurology.
Lodo Therapeutics
Series A in 2016
Lodo Therapeutics Corporation is a drug discovery and development company dedicated to creating novel therapeutics derived from natural sources. It focuses on addressing significant health challenges, particularly resistant infectious diseases and cancers, by collaborating with global pharmaceutical companies and leading non-governmental organizations. Founded to realize the scientific vision of Dr. Sean Brady from Rockefeller University, Lodo Therapeutics utilizes a genome-based, culture-independent platform to discover and characterize small molecules sourced from environmental microbial DNA. This innovative approach leverages advancements in DNA sequencing and bioinformatics to explore the untapped potential of microbial evolution, aiming to identify therapeutically valuable pharmaceutical products. Headquartered in New York City at the Alexandria Center for Life Science, Lodo Therapeutics is committed to harnessing the power of nature in the fight against undruggable targets and high unmet medical needs.
Petra Pharma
Series A in 2016
Petra Pharma Corporation is a clinical-stage pharmaceutical company based in New York that focuses on discovering and developing therapies targeting phosphoinositide (PI) signaling pathways. Established in 2015, the company aims to create novel small molecules that address serious medical conditions, particularly cancer and metabolic diseases. By honing in on unique enzyme targets involved in critical cellular processes such as cell division, growth, trafficking, and signaling, Petra Pharma seeks to develop innovative treatments that can enhance human health and provide new options for healthcare providers.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.